There were positive trends in the data regarding the impact on healthcare utilisation outcomes, but in general these did not reach statistical significance ( p < 0.05) within the 6-month follow-up period in intervention patients when compared with control patients.
← all excerpts
General practitioner practice-based pharmacist input to medicines optimisation in the UK: pragmatic, multicenter, randomised, controlled trial.
1
0.0500
0.0500